biosimiliainnerbanner1

HIV Nosode

HIV nosode is a multi-spectrum therapeutic agent which was developed from HIV type I and type II organisms, with the help of a team of scientists. The preparation has undergone several studies such as scientific development (1), human study in healthy volunteers (2), clinical trial (3) as well as in-vitro studies. The study has shown its safe use in humans.

This is major medicine in the nosode category, which has a potential of helping deep seated diseases arising due to immunological aetiology. As the HIV virus has a capacity to influence many organs and systems in the human body, so as the HIV nosode has potential to bring therapeutic benefits for a range of immunologically mediated diseases.

Clinical indications

  1. Wide range of immunologically mediated diseases
  2. Auto-immune diseases like Psoriasis, Eczema, Pemphigus, Rheumatoid Arthritis, etc.
  3. Recurring and chronic infections (as adjuvant therapy)
  4. HIV infection (as adjuvant therapy)
  5. Cancer
  6. Others

References

  1. “Scientific method of preparing homoeopathic nosodes” Indian Journal of Research in Homoeopathy [serial online] 2014 [cited 2014 Nov 13];9: 25-33. Available from: http://www.ijrh.org/text.asp?2014/8/3/166/141740
  2. “HIV Nosode: The Homeopathic Pathogenetic Trial,” by Rajesh Shah, MD, published in Forschende Komplementärmedizin / Research in Complementary Medicine, Germany, June 2015.  Link: http://www.karger.com/Article/Abstract/435845
  3. “Clinical trial for evaluation of a Human Immunodeficiency Virus nosode in the treatment for Human Immunodeficiency Virus‑ Infected individuals”; Indian Journal of Research in Homoeopathy / Vol. 9 / Issue 1 / Jan-Mar 2015 http://www.ijrh.org/article.asp?issn=0974-7168;year=2015;volume=9;issue=1;spage=25;epage=33;aulast=Shah